366 related articles for article (PubMed ID: 30269739)
1. MicroRNA-301b promotes cell proliferation and apoptosis resistance in triple-negative breast cancer by targeting CYLD.
Song H; Li D; Wu T; Xie D; Hua K; Hu J; Deng X; Ji C; Deng Y; Fang L
BMB Rep; 2018 Nov; 51(11):602-607. PubMed ID: 30269739
[TBL] [Abstract][Full Text] [Related]
2. miR-501 is upregulated in cervical cancer and promotes cell proliferation, migration and invasion by targeting CYLD.
Sanches JGP; Xu Y; Yabasin IB; Li M; Lu Y; Xiu X; Wang L; Mao L; Shen J; Wang B; Hou L; Ju J; Zhao J; Song B
Chem Biol Interact; 2018 Apr; 285():85-95. PubMed ID: 29477382
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of miR‑181b inhibits human colon cancer cell proliferation by targeting CYLD and inhibiting the NF‑κB signaling pathway.
Yang X; Sun Y; Zhang Y; Han S
Int J Mol Med; 2020 Nov; 46(5):1755-1764. PubMed ID: 32901872
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-362 induces cell proliferation and apoptosis resistance in gastric cancer by activation of NF-κB signaling.
Xia JT; Chen LZ; Jian WH; Wang KB; Yang YZ; He WL; He YL; Chen D; Li W
J Transl Med; 2014 Feb; 12():33. PubMed ID: 24495516
[TBL] [Abstract][Full Text] [Related]
5. WBP2 Downregulation Inhibits Proliferation by Blocking YAP Transcription and the EGFR/PI3K/Akt Signaling Pathway in Triple Negative Breast Cancer.
Song H; Wu T; Xie D; Li D; Hua K; Hu J; Fang L
Cell Physiol Biochem; 2018; 48(5):1968-1982. PubMed ID: 30092563
[TBL] [Abstract][Full Text] [Related]
6. microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression.
Guo GC; Wang JX; Han ML; Zhang LP; Li L
Cell Oncol (Dordr); 2017 Apr; 40(2):157-166. PubMed ID: 28054302
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24.
Li Z; Meng Q; Pan A; Wu X; Cui J; Wang Y; Li L
Oncotarget; 2017 Mar; 8(12):19455-19466. PubMed ID: 28038450
[TBL] [Abstract][Full Text] [Related]
8. Tumor suppressor role of microRNA-1296 in triple-negative breast cancer.
Phan B; Majid S; Ursu S; de Semir D; Nosrati M; Bezrookove V; Kashani-Sabet M; Dar AA
Oncotarget; 2016 Apr; 7(15):19519-30. PubMed ID: 26799586
[TBL] [Abstract][Full Text] [Related]
9. MiR-25-3p promotes the proliferation of triple negative breast cancer by targeting BTG2.
Chen H; Pan H; Qian Y; Zhou W; Liu X
Mol Cancer; 2018 Jan; 17(1):4. PubMed ID: 29310680
[TBL] [Abstract][Full Text] [Related]
10. MiR-890 inhibits proliferation and invasion and induces apoptosis in triple-negative breast cancer cells by targeting CD147.
Wang C; Xu C; Niu R; Hu G; Gu Z; Zhuang Z
BMC Cancer; 2019 Jun; 19(1):577. PubMed ID: 31196010
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of miR-182 promotes apoptosis via regulating RIP1 deubiquitination in TNF-α-treated triple-negative breast cancer cells.
Wo L; Lu D; Gu X
Tumour Biol; 2016 Oct; 37(10):13733-13742. PubMed ID: 27476169
[TBL] [Abstract][Full Text] [Related]
12. miR-20a induces cisplatin resistance of a human gastric cancer cell line via targeting CYLD.
Zhu M; Zhou X; Du Y; Huang Z; Zhu J; Xu J; Cheng G; Shu Y; Liu P; Zhu W; Wang T
Mol Med Rep; 2016 Aug; 14(2):1742-50. PubMed ID: 27357419
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA GAS5 suppresses triple negative breast cancer progression through inhibition of proliferation and invasion by competitively binding miR-196a-5p.
Li S; Zhou J; Wang Z; Wang P; Gao X; Wang Y
Biomed Pharmacother; 2018 Aug; 104():451-457. PubMed ID: 29793177
[TBL] [Abstract][Full Text] [Related]
14. miR-17-5p suppresses cell proliferation and invasion by targeting ETV1 in triple-negative breast cancer.
Li J; Lai Y; Ma J; Liu Y; Bi J; Zhang L; Chen L; Yao C; Lv W; Chang G; Wang S; Ouyang M; Wang W
BMC Cancer; 2017 Nov; 17(1):745. PubMed ID: 29126392
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-211-5p suppresses tumour cell proliferation, invasion, migration and metastasis in triple-negative breast cancer by directly targeting SETBP1.
Chen LL; Zhang ZJ; Yi ZB; Li JJ
Br J Cancer; 2017 Jun; 117(1):78-88. PubMed ID: 28571042
[TBL] [Abstract][Full Text] [Related]
16. miR-331-3p Suppresses Cell Proliferation in TNBC Cells by Downregulating NRP2.
Zhao M; Zhang M; Tao Z; Cao J; Wang L; Hu X
Technol Cancer Res Treat; 2020; 19():1533033820905824. PubMed ID: 32174262
[TBL] [Abstract][Full Text] [Related]
17. MiR-454 prompts cell proliferation of human colorectal cancer cells by repressing CYLD expression.
Liang HL; Hu AP; Li SL; Xie JP; Ma QZ; Liu JY
Asian Pac J Cancer Prev; 2015; 16(6):2397-402. PubMed ID: 25824771
[TBL] [Abstract][Full Text] [Related]
18. Research on mechanism of miR-130a in regulating autophagy of bladder cancer cells through CYLD.
Dai H; Liu C; Liu Y; Zhang Z; Peng C; Wang Z; Zheng J; Li C; Yu W; Cheng F
J BUON; 2020; 25(3):1636-1642. PubMed ID: 32862616
[TBL] [Abstract][Full Text] [Related]
19. miR-182 controls cell growth in gastrointestinal stromal tumors by negatively regulating CYLD expression.
Ling T; Yu F; Cao H
Oncol Rep; 2018 Dec; 40(6):3705-3713. PubMed ID: 30542706
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-498 promotes proliferation and migration by targeting the tumor suppressor PTEN in breast cancer cells.
Chai C; Wu H; Wang B; Eisenstat DD; Leng RP
Carcinogenesis; 2018 Sep; 39(9):1185-1196. PubMed ID: 29985991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]